Navigation Links
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
Date:5/3/2012

THURSDAY, May 3 (HealthDay News) -- The use of the anti-HIV drug tenofovir during pregnancy appears to be safe for infants, new research suggests.

In combination with other anti-HIV drugs, tenofovir (Viread) is the first line of treatment for adults with HIV, the virus that causes AIDS. These findings should reassure pregnant women who are taking tenofovir, the researchers said.

The study was conducted by the U.S. National Institutes of Health network because previous studies showed that laboratory animals exposed to tenofovir in the womb were smaller at birth than those that were not exposed to the drug.

The new study included 2,000 infants born to HIV-positive mothers between 2003 and 2010 in the United States. Infants born to mothers who took tenofovir during pregnancy did not weigh less at birth and did not have shorter length than those born to women who did not take the drug.

At 1 year of age, however, children born to mothers who took tenofovir during pregnancy were slightly shorter and had slightly smaller head circumference (an average of about 1 centimeter) than children whose mothers did not take the drug, the investigators found.

The researchers said further studies should be conducted to follow the children as they grow and develop in order to identify any potential long-term effects of taking tenofovir during pregnancy.

The study was released online April 26 in advance of publication in an upcoming print issue of the journal AIDS.

"This study produced reassuring information regarding the use of tenofovir," first author Dr. George Siberry, of the Pediatric, Adolescent and Maternal AIDS Branch of the U.S. National Institute of Child Health and Human Development, said in a National Institutes of Health news release.

"Although further research is needed ... our findings favor the use of tenofovir in pregnancy to ensure good outcomes in the mother and prevent transmission of HIV to the infant," Siberry added.

More information

The New Mexico AIDS Education and Training Center has more about HIV and pregnancy.

-- Robert Preidt

SOURCE: U.S. National Institute of Child Health and Human Development, news release, May 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tenofovir gel dropped from HIV prevention trial in women because it was not effective
2. Major HIV prevention trial in women to drop oral tenofovir arm
3. Next steps for Tenofovir gel: CONRAD and TIA sign license agreement
4. Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue
5. Tenofovir gel provides high level of protection against HIV in rectal tissue
6. Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use
7. Heroin Addicts Have Higher Pain Sensitivity, Even During Treatment
8. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
9. Exercise improves quality of life during breast cancer treatment
10. Few young women with cancer take steps to preserve fertility during treatments
11. Use of anesthesia providers during GI procedures is growing, but may be unnecessary
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
(Date:2/20/2017)... ... ... Clearwave is the leading provider in patient ... of touch screen terminals. Both companies will be showcasing their solutions at Posiflex ... Posiflex is helping to bridge the gap between healthcare hardware and software through ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... FL (PRWEB) , ... February 20, 2017 , ... ... gift from Constellation Brands to purchase a new ultrasound-enhanced thrombolysis machine, a state-of-the-art ... waves. The gift was facilitated by the Pepin Family Foundation. , “We greatly ...
(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, Inc., a ... with Healthwise ® at HIMSS 2017 to showcase a breakthrough ... health education, technology and services, will demonstrate a voice-powered knowedge assistant based on ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette White, ... Pet Life Radio network. The episode, which was posted this week, features a ... factors led to Park Cities Pet Sitter’s being awarded the 2017 National Association of ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... PUNE, India , February 17, 2017 ... Product (Airborne Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination ... Global Forecast to 2021" published by MarketsandMarkets, the market is expected ... in 2016, at a CAGR of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)...   FormFast , the leader in electronic forms ... Engage , one of the largest MEDITECH partners ... will serve as the forms automation and electronic signature ... .  FormFast is a MEDITECH collaborative ... enhance the electronic health record. FormFast,s technology bridges clinical ...
Breaking Medicine Technology: